secwatch / observer

8-K filed October 15, 2025, 7:59 PM ET ticker ZION CIK 0000109380

other material confidence high sentiment negative materiality 0.75

Zions Bancorporation takes $60M provision, $50M charge-off on two commercial loans due to apparent fraud

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/

Bank took $60M provision and $50M charge-off on two commercial loans in Q3 2025 due to apparent misrepresentations and defaults.
Loans were extended by California Bank & Trust division; obligors have not responded to demands and notices.
Bank commenced lawsuit in California against guarantors (Obligors) for full recovery of outstanding amounts.
Bank believes situation is isolated and plans to engage counsel for independent review.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000109380-25-000118
form_type: 8-K
ticker: ZION
cik: 0000109380
company_name: ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
filed_at: 2025-10-15T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.775675+00:00
generated_at: 2026-05-17T03:40:51.575358+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000109380-25-000118
json_url: https://secwatch.observer/filing/0000109380-25-000118.json
markdown_url: https://secwatch.observer/filing/0000109380-25-000118.md
text_url: https://secwatch.observer/filing/0000109380-25-000118.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/109380/000010938025000118/0000109380-25-000118-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/109380/000010938025000118/zion-20251015.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

XMTR

Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M

Xometry, Inc. June 2, 2026, 5:26 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

HYMC

Hycroft TRS shows $10B NPV at spot; 51-year mine life with 10.4M oz gold

HYCROFT MINING HOLDING CORP June 2, 2026, 4:31 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TTI

TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex

TETRA TECHNOLOGIES INC June 2, 2026, 4:26 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CEG

Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase

Constellation Energy Corp June 2, 2026, 4:15 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CNL Strategic Capital, LLC

Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks

CNL Strategic Capital, LLC June 2, 2026, 4:04 PM ET other_material Items 1.01, 2.03, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

INMB

INmune Bio reports statistically significant white matter MRI biomarker in Phase 2 Alzheimer's trial

Inmune Bio, Inc. June 2, 2026, 4:00 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

QMCO

Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance

QUANTUM CORP /DE/ June 2, 2026, 10:41 AM ET other_material Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CELC

Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial

Celcuity Inc. June 2, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000109380-25-000118

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.